4//SEC Filing
Ronaghi Mostafa 4
Accession 0001599298-25-000025
CIK 0001599298other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:11 PM ET
Size
437.2 KB
Accession
0001599298-25-000025
Insider Transaction Report
Form 4
Ronaghi Mostafa
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02+35,000→ 35,000 totalExercise: $18.35Exp: 2035-01-02→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001441876
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:11 PM ET
- Size
- 437.2 KB